Synthesis and antimicrobial activity of molecular hybrids based on eugenol and chloramphenicol pharmacophores.

Resumo

In the constant search for new pharmacological compounds, molecular hybridisation is a well-known technique whereby two or more known pharmacophoric subunits are combined to create a new “hybrid” compound. This hybrid is expected to maintain the characteristics of the original compounds whilst demonstrating improvements to their pharmacological action. Accordingly, we report here a series of molecular hybrid compounds based upon eugenol and chloramphenicol pharmacophores. The hybrid compounds were screened for their in vitro antimicrobial potential against Gram-negative and Gram-positive bacteria and also rapidly growing mycobacteria (RGM). The results highlight that the antimicrobial profiles of the hybrid compounds improve in a very clear fashion when moving through the series. The most prominent results were found when comparing the activity of the hybrid compounds against some of the multidrug-resistant clinical isolates of Pseudomonas aeruginosa, methicillin-resistant clinical isolates of Staphylococcus aureus (MRSA) and clinical isolates of rapidly growing mycobacteria.

Descrição

Palavras-chave

Hybridisation, Rapidly growing mycobacteria

Citação

OLIVEIRA, L. M. et al. Synthesis and antimicrobial activity of molecular hybrids based on eugenol and chloramphenicol pharmacophores. Folia Microbiologica, abr. 2023. Disponível em: <https://link.springer.com/article/10.1007/s12223-023-01057-9>. Acesso em: 01 ago. 2023.

Avaliação

Revisão

Suplementado Por

Referenciado Por